On November 12, 2019, the registration number of the two products of our company's oral solid medicine HDPE bottle and antibiotic bottle with aluminum plastic composite cover was shown as "a" in the "registration information publicity of API, pharmaceutical excipients and drug packaging materials" of the drug review center of the State Drug Administration, which means that our company's product has been approved Packaging materials used in marketed preparations.

So far, our company has successfully associated four kinds of product registration numbers with pharmaceutical enterprises, namely, medical low-density polyethylene film and bag, sterile raw material medical low-density polyethylene film and bag, oral solid medical high-density polyethylene bottle, and antibiotic bottle with aluminum-plastic composite cover, which means that other drug preparation applicants can safely use our company's drug packaging materials to Drug declaration, so as to reduce the risk of traditional Chinese medicine packaging materials in the related review process.

On July 16, 2019, the State Food and Drug Administration issued a notice (No. 56, 2019) on further improving the related review, approval and supervision of drugs. According to the requirements of the notice, other registered products of our company will also be changed to "a". We will continue to pay attention to policy changes and actively carry out this work. Our company is in line with the concept and attitude of win-win cooperation and common development to work together with pharmaceutical enterprises to make good packaging for the world's good medicine, so that human health is more guaranteed!